sk&f 82958 has been researched along with piperidines in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brotchie, JM; Crossman, AR; Maneuf, YP | 1 |
Heron-Maxwell, CL; O'Neill, MF; Shaw, G | 1 |
Bisogno, T; Brotchie, JM; Crossman, AR; Di Marzo, V; Hill, MP | 1 |
Bishop, C; Daut, GS; Walker, PD | 1 |
Berkowitz, JS; Caine, SB; Gabriel, KI; Gold, LH; Koob, GF; Thomsen, M; Tonegawa, S; Xu, M; Zhang, J | 1 |
5 other study(ies) available for sk&f 82958 and piperidines
Article | Year |
---|---|
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
Topics: Animals; Basal Ganglia; Benzazepines; Benzoxazines; Dopamine Agonists; gamma-Aminobutyric Acid; Locomotion; Male; Morpholines; Naphthalenes; Nerve Tissue Proteins; Parkinson Disease, Secondary; Piperidines; Pyrazoles; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Drug; Reserpine; Rimonabant | 1997 |
5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
Topics: Aminopyridines; Amphetamine; Animals; Benzazepines; Cocaine; Dizocilpine Maleate; Dopamine Agonists; Drug Interactions; Female; Fluorobenzenes; Indoles; Mice; Motor Activity; Piperidines; Ritanserin; Serotonin Antagonists | 1999 |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Topics: Animals; Arachidonic Acids; Benzazepines; Cannabinoid Receptor Modulators; Cannabinoids; Dopamine Agonists; Endocannabinoids; Globus Pallidus; Glycerides; Humans; Male; Motor Activity; Parkinsonian Disorders; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Reserpine; Rimonabant; Substantia Nigra; Tissue Distribution | 2000 |
Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
Topics: Animals; Benzazepines; Biogenic Monoamines; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Electrochemistry; Fluorobenzenes; Male; Microinjections; Motor Activity; Neostriatum; Oxidopamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Serotonin Antagonists; Spiro Compounds; Sulfonamides; Sympathectomy, Chemical; Sympatholytics | 2005 |
Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Cocaine; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Hypnotics and Sedatives; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Piperidines; Receptors, Dopamine D1; Reinforcement, Psychology; Remifentanil; Self Administration; Statistics, Nonparametric | 2007 |